Outset Medical Secures $40M HCA Contract for Tablo System Refresh Through 2028
OM sits 57% above its 52-week low of $3.
Summary
Outset Medical has secured a significant $40 million contract with HCA Management Services to refresh and expand HCA's fleet of Tablo Hemodialysis Systems. This follows an 8-K filing earlier today disclosing the agreement. The committed capital purchase, net of rebates, will see deliveries commence in 2026 and continue through 2028. This is a highly material contract relative to Outset Medical's current market capitalization, providing a substantial and committed revenue stream for the next few years. The amendment also establishes a framework for potential future growth beyond current sites.
At the time of this announcement, OM was trading at $4.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $74.4M. The 52-week trading range was $3.00 to $21.36. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.